Search Results - "Asher, Constance"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Speciation of Ferriprotoporphyrin IX in Aqueous and Mixed Aqueous Solution Is Controlled by Solvent Identity, pH, and Salt Concentration by Asher, Constance, de Villiers, Katherine A., Egan, Timothy J.

    Published in Inorganic chemistry (17-08-2009)
    “…The speciation of ferriprotoporphyrin IX (Fe(III)PPIX) in aqueous and mixed aqueous−organic solvents has been investigated by UV−vis, 1H NMR, magnetic, and…”
    Get full text
    Journal Article
  2. 2

    In vitro biotransformation, in vivo efficacy and pharmacokinetics of antimalarial chalcones by Gutteridge, Clare E, Thota, Darshan S, Curtis, Sean M, Kozar, Michael P, Li, Qigui, Xie, Lisa, Zhang, Jing, Melendez, Victor, Asher, Constance O, Luong, Thulan T, Gerena, Lucia, Nichols, Daniel A, Montip, Gettayacamin

    Published in Pharmacology (01-01-2011)
    “…4'-n-Butoxy-2,4-dimethoxy-chalcone (MBC) has been described as protecting mice from an otherwise lethal infection with Plasmodium yoelii when dosed orally at…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    The role of in vitro ADME assays in antimalarial drug discovery and development by Shearer, Todd W, Smith, Kirsten S, Diaz, Damaris, Asher, Constance, Ramirez, Julio

    “…The high level of attrition of drugs in clinical development has led pharmaceutical companies to increase the efficiency of their lead identification and…”
    Get more information
    Journal Article
  7. 7

    Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382 by Hutzler, J Matthew, Cerny, Matthew A, Yang, Young-Sun, Asher, Constance, Wong, Diane, Frederick, Kosea, Gilpin, Kyle

    Published in Drug metabolism and disposition (01-10-2014)
    “…BIBX1382 was an epidermal growth factor receptor inhibitor under clinical investigation for treatment of cancer. This candidate possessed an attractive…”
    Get full text
    Journal Article